Document is current
Any future updates will be listed below
-
Authors
Iacoboni, Gloria https://orcid.org/0000-0003-0805-9288
Rejeski, Kai https://orcid.org/0000-0003-3905-0251
Navarro, Víctor
van Meerten, Tom https://orcid.org/0000-0002-5581-6950
Rampotas, Alex
Martín-López, Ana África
Bastos, Mariana
Benzaquén, Ana
Reguera-Ortega, Juan Luis
Carpio, Cecilia
Roddie, Claire
López-Corral, Lucia https://orcid.org/0000-0003-1908-5596
Delgado-Serrano, Javier
Landwehr, Maria
Stock, Sophia https://orcid.org/0000-0002-5072-5013
Silva de Tena, Pablo
Abrisqueta, Pau
de Boer, Janneke https://orcid.org/0000-0002-0221-1835
Martin Garcia-Sancho, Alejandro https://orcid.org/0000-0001-6330-1028
Hernani, Rafael
Kwon, Mi https://orcid.org/0000-0002-3855-7774
Subklewe, Marion https://orcid.org/0000-0001-9154-9469
O’Reilly, Maeve
Barba, Pere
- License Information
-
More Information
Article History
Received: 11 January 2025
Revised: 6 March 2025
Accepted: 20 March 2025
First Online: 1 April 2025
Competing interests
: GI Consultancy and Honoraria: Novartis, Roche, Kite/Gilead, Bristol-Myers Squibb, Abbvie, Janssen, Sandoz, Miltenyi, AstraZeneca. KR Kite/Gilead: Honoraria, research funding and travel support; Novartis: Honoraria; BMS/Celgene: Consultancy, Honoraria. Pierre-Fabre: Travel support. CR Honoraria from Kite/Gilead, Novartis, BMS, Amgen, Autolus, Janssen, Cellistic, Miltenyi. JD Honoraria from Kite-Gilead, Novartis, Bristol Myers Squibb, Janssen. CC Regeneron: Consultancy/Advisory, BMS: Consultancy/Advisory, Takeda: Consultancy/Advisory/Honoraria, Novartis: Honoraria. PA Honoraria from Roche, AbbVie, Gilead, BMS, AstraZeneca, Janssen, Incyte. AMGS Honoraria and or consulting fees: Abbvie, AstraZeneca, BeiGene, BMS, Genmab, Gilead / Kite, GSK, Ideogen, Incyte, Janssen, Kyowa Kirin, Lilly, Miltenyi, Regeneron, Roche, Sobi, Takeda. Research support: Gilead / Kite. RH Research: Gilead. Travel support: Gilead. Honoraria: Gilead, Janssen. MK Consulting and lectures: Gilead, Jazz, Pfizer. MS receives industry research support from Amgen, Bristol-Myers Squibb/Celgene, Gilead, Janssen, Miltenyi Biotec, Morphosys, Novartis, Roche, Seattle Genetics, and Takeda, and serves as a consultant/advisor to AvenCell, CDR-Life, Ichnos Sciences, Incyte Biosciences, Janssen, Molecular Partners, and Takeda. She serves on the speakers’ bureau at Amgen, AstraZeneca, BMS/Celgene, Gilead, GSK, Janssen, Novartis, Pfizer, Roche, and Takeda. M.O. Honoraria: Kite, Novartis, Janssen. Advisory Board: Kite, Autolus. PB Allogene: Honoraria; Amgen: Honoraria; BMS: Honoraria; Kite/Gilead: Honoraria; Janssen: Honoraria; Jazz Pharmaceuticals: Honoraria; Miltenyi: Honoraria; Novartis: Honoraria; Nektar: Honoraria.
